Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 15:416:117013.
doi: 10.1016/j.jns.2020.117013. Epub 2020 Jul 4.

Correlations between COVID-19 and burden of dementia: An ecological study and review of literature

Affiliations
Review

Correlations between COVID-19 and burden of dementia: An ecological study and review of literature

M Reza Azarpazhooh et al. J Neurol Sci. .

Abstract

Introduction: Current evidence on the association between COVID-19 and dementia is sparse. This study aims to investigate the associations between COVID-19 caseload and the burden of dementia.

Methods: We gathered data regarding burden of dementia (disability-adjusted life years [DALYs] per 100,000), life expectancy, and healthy life expectancy (HALE) from the Global Burden of Disease (GBD) 2017 study. We obtained COVID-19 data from Our World in Data database. We analyzed the association of COVID-19 cases and deaths with the burden of dementia using Spearman's rank correlation coefficient.

Results: Globally, we found significant positive (p < .001) correlations between life expectancy (r = 0.60), HALE (r = 0.58), and dementia DALYs (r = 0.46) with COVID-19 caseloads. Likewise, we found similar correlations between life expectancy (r = 0.60), HALE (r = 0.58) and dementia DALYs (r = 0.54) with COVID-19 mortality.

Conclusion: Health policymakers should clarify a targeted model of disease surveillance in order to reduce the dual burden of dementia and COVID-19.

Keywords: COVID-19; Dementia; Global burden of disease; Mortality.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1
A. Correlation between Alzheimer's disease and other dementias DALYs rate and: A. Total number of COVID-19 cases per million. B. Total number of COVID-19 deaths per million.

Similar articles

Cited by

References

    1. GBD 2016 Dementia Collaborators Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:88–106. - PMC - PubMed
    1. Rogers N.T., Steptoe A., Cadar D. Frailty is an independent predictor of incident dementia: evidence from the English longitudinal study of ageing. Sci. Rep. 2017;7:15746. - PMC - PubMed
    1. Nikolich-Zugich J., Knox K.S., Rios C.T., Natt B., Bhattacharya D., Fain M.J. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. 2020;42:505–514. - PMC - PubMed
    1. Azarpazhooh M.R., Avan A., Cipriano L.E., Munoz D.G., Sposato L.A., Hachinski V. Concomitant vascular and neurodegenerative pathologies double the risk of dementia. Alzheimers Dement. 2018;14:148–156. - PubMed
    1. Brown E.E., Kumar S., Rajji T.K., Pollock B.G., Mulsant B.H. Anticipating and mitigating the impact of the COVID-19 pandemic on Alzheimer’s disease and related dementias. Am. J. Geriatr. Psychiatry. 2020;S1064-7481(20) (30294-3) - PMC - PubMed